In this @-week , phase III , randomized , double-blind placebo-controlled study , adults who were receiving metformin administered twice daily ( @mg/day ) and had inadequate glycaemic control were randomized @:@:@:@ to receive dapagliflozin twice daily ( @ or @mg ) , placebo or dapagliflozin @mg once daily ( which was included as a benchmark ) .